Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.

Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment...

Full description

Bibliographic Details
Published in:Clinical Infectious Diseases
Main Authors: Plymoth, Martin, Lundqvist, Robert, Nystedt, Anders, Sjöstedt, Anders, Gustafsson, Tomas N
Format: Article in Journal/Newspaper
Language:English
Published: Silverchair Information Systems 2024
Subjects:
Francisella tularensis
ciprofloxacin
doxycycline
outcome
treatment
Northern Sweden
Online Access:https://doi.org/10.1093/cid/ciae098
https://pubmed.ncbi.nlm.nih.gov/38393822
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/
Description
Summary:Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment outcomes of laboratory-confirmed tularemia cases over an 11-year period in Northern Sweden.

Similar Items